Ask The Board

  1. How Can I Prepare To Join And Serve On A Board Of Directors? 5/2/2022

    See the answer from Allan Shaw, an independent board member, CalciMedica, consulting CFO, and special advisor.

  2. How Can Digital Technology Improve The Treatment Of Neurological Disorders? 5/2/2022

    See the answer from John Reynders, VP, R&D strategy, program management, data science at Alexion Pharmaceuticals.

  3. Following The Approval Of Biogen’s Aduhelm, There Has Been Talk About “Reining In” The FDA’s Accelerated Approval Pathway. How Important Is Accelerated Approval For Rare Disease Drugs? 5/2/2022

    See the answer from John Crowley, chairman and CEO of Amicus Therapeutics.

  4. What Technologies Do You Anticipate Disrupting Vaccine Manufacturing And Why? 4/1/2022

    See the answer from Jacks Lee, SVP global manufacturing and supply at Merck.

  5. What Have Been The Most Valuable Lessons Learned Over The Past Two Years? 4/1/2022

    See the answer from Anu Hans, VP of strategic initiatives at Janssen Supply Chain.

  6. What Would You Say To An Executive Who States They Don’t Know How To Manage/Lead Millennials? 4/1/2022

    See the answer from Mary Rose Keller, VP of clinical operations at Acrivon Therapeutics.

  7. What Do You See As The Most Pressing Issue Biopharma Leaders Should Be Paying Attention To And Why? 3/1/2022

    See the answer from John Lamattina, the former president of Pfizer R&D who is now a senior partner at PureTech Health.

  8. Why Does Diversity In Clinical Trials Continue To Be A Challenge For Biopharma Companies, And What Thoughts/Ideas Do You Have On How To Overcome? 3/1/2022

    See the answer from Mitchell Katz, Ph.D., VP, development operations at Ferring Pharmaceuticals.

  9. What Industry-Related Political Legislation Are You Following Most Closely? 3/1/2022

    See the answer from Tom DiLenge, senior partner for global public policy, regulatory and governmental strategy at Flagship Pioneering.

  10. How Do You See The Current Revolution In Process Development And Manufacturing Of Cell And Gene Therapies Changing The Regulatory Landscape For Approvals Of Personalized Medicines? 2/1/2022

    See the answer from Charlene Banard, the former global head of cell & gene therapy, technical operations at Novartis.